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Save British Science
What is it famous for?  It’s not really,
but whenever science policy is
discussed in the UK media,
government, or in industry, it’s a fair
bet that Save British Science (SBS)
will be in the fray. SBS is the leading
lobby group for science in the UK.
The ‘science’ it aims to save includes
any activity that develops and
applies scientific understanding,
including medicine, mathematics,
engineering, technology, and so on.
How did SBS start?  A handful of
British scientists, among them the
eminent physiologist Dennis Noble,
got together in autumn 1985 to
discuss their concerns over the
neglect of science by the then
Conservative government and, more
specifically, the lack of research
funding. They decided to make their
opinions known by placing an
advertisement in the Times
newspaper. Their concerns clearly
struck a chord with others, because
donations flooded in, and in early
1986 they placed an advertisement
entitled ‘Save British Science’. The
remaining money was used to found
the society of the same name.
How does SBS think science could be
saved?  The society promotes a range
of policies aimed at halting the decay
in the academic infrastructure,
promoting innovative university
research (to reverse the push towards
‘safe’ science), encouraging better
relations between university-based
research and industry, and
broadening the school science
curriculum at high school level. (For
more details, see the SBS web site at
http://dspace.dial.pipex.com/sbs)
How successful has it been? For a
fairly small group (1700 members
from all levels of science and
engineering), run on a shoestring,
SBS makes an extraordinarily large
splash in the mainstream media.
Although it’s done its share of rabble-
rousing, SBS has a reputation for
providing balanced, no-nonsense
facts on science policy.
Does it have the ear of the Government?
SBS met with the present Prime
Minister, Tony Blair, before his
recent election victory, and has
regular meetings with the cabinet
minister responsible for science.
Many of the new government’s
science policies overlap with key aims
of SBS, and the society was delighted
at Blair’s recognition of the “decay in
academic infrastructure” and desire
to “reinvigorate the university
science base.” But SBS won’t be
getting too cosy with Labour. It urged
Tony Blair to block cuts in science
funding planned by the previous
government, but no block was
evident in Labour’s first budget.
What is the prognosis for academic
science in the UK?  The recently
published Dearing Committee
Report — the broadest inquiry into
British higher education for 30 years
— confirmed that urgent injection of
new government funds into the
universities is needed, a finding that
was warmly welcomed by SBS. But
the report may have left the door
open for further reshuffling of funds
between the two branches of the
academic funding system (the
Higher Education Funding Councils
and the Research Councils), which
the society says would do nothing to
cure the chronic under-funding of
the university infrastructure.
Who runs SBS?  An Executive
Committee, headed by the Director,
nuclear physicist John Mulvey, and
an Advisory Council composed of
high-profile industrialists and
scientists, such as John Kendrew,
Richard Doll and Richard Sykes,
CEO of Glaxo Wellcome. Mulvey
has been a driving force behind SBS
since the start, and has gained a
reputation for his painstaking
debunking of government figures on
science funding. He has often
succeeded in causing embarrassment
by revealing creative accounting
behind claims of ‘new’ science
funding. But after 10 years, Mulvey
is ready to pass over the mantle, and
SBS is seeking a new Director.
Are there any more changes afoot?
SBS plans to shift its activities up
another gear. It has launched a
program to increase its income by
regular subscriptions from
universities, science societies and
industry. As a result, the new
Director will be able to establish an
even higher profile from a central
London office. Sadly, SBS doesn’t
look like becoming redundant yet.
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Several research papers, (reviewed in
[1]), have revealed that chemokine
receptors can function as co-
receptors with CD4 for human
immunodeficiency virus 1 (HIV-1)
invasion. Different strains of HIV-1
use different chemokine receptors
for viral fusion. Macrophage-tropic
strains of HIV-1 use mainly CCR5,
whereas the T-cell tropic strains of
HIV-1 use CXCR4 [1].
Three recent research papers have
shown that a 32-base-pair deletion in
the human CCR5 gene (CCR5 ∆32
allele) produces a mutant protein that
is severely truncated and is not
expressed on the cell surface [2–4].
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Therefore, selection against this allele
must be almost absent, as people who
have inherited two copies of the
mutant CCR5 gene do not have any
observable deleterious phenotype yet
they are remarkably resistant to
infection by HIV-1 [2–4]. The high
prevalence of the mutant CCR5 ∆32
allele — around 20% in some
populations — has fueled speculation
that it might have become common as
the result of selective pressure
brought about by exposure to an
unknown pathogen that utilized
CCR5 at some time in the past [3,4].
We wish to point out, however,
that there are examples of
polymorphisms — the rhesus (Rh)
blood group alleles for instance —
that are common in a population
without any apparent selective
advantages for the host. Around 15%
of Caucasians are Rh negative [5],
that is they lack the rhesus D protein
[6]. We would like to speculate that
perhaps the CCR5 ∆32 mutation,
like the rhesus polymorphisms, did
not become common in a population
through any selective advantage to
its host. If this is the case, what are
the likeliest explanations for how
this mutation could have arisen?
While gazing at the sequence of
CCR5, we noticed tandem repeats in
the nucleotide sequence of CCR5
(Fig. 1). These tandem nucleotide
repeats suggested an alternative
explanation for the relative
abundance of CCR5 ∆32 within
some populations. Direct repeats are
also a hallmark of replication
slippage, gap misrepair and unequal
homologous recombination-based
models of deletion mutagenesis.
Rather than supposing that all
individuals with CCR5 ∆32 share a
common ancestor who had a relatively
rare deletion event, we propose that
the generation of CCR5 ∆32 could
arise independently in a population as
a result of unequal homologous
meiotic recombination. We consider
replication slippage and gap misrepair
to be unlikely because there are no
energetically favorable hairpins within
the sequence and the deletion is
longer than expected for misrepair. In
the absence of selective pressure for
the normal allele, CCR5 ∆32 might be
expected to be relatively frequent.
Furthermore, all individuals who have
CCR5 ∆32 need not share a common
ancestor, as the deletion would be
expected to arise in a number of
unrelated individuals in each
generation. Our explanation does not
require a prior history of natural
selection by an unknown agent to
preserve the deletion allele within a
particular human population.
Figure 1 depicts the generation of
CCR5 ∆32. Misalignment of the
parental sequences and a crossover
event anywhere within the repeat
regions would result in the 32 bp
deletion. Such a mechanism for
introducing variation into the human
population is not without precedent.
Independent mutations presumably
resulting from misalignment of the
parental sequences during meiosis
followed by unequal homologous
recombination are known to give rise
to variation at the ß-globin locus [7].
There are at least two other
possible explanations for the presence
of CCR5 ∆32 in human populations
(not shown). First, if homologous
recombination events were to be
initiated by a cleavage of both chains
of the DNA double helix (a double
chain break) within or near CCR5,
then the preferential transfer of one
end of the broken parental DNA
molecule might give rise to
nonreciprocal ‘crossing over’ as
described by Stahl et al. [8]. Second, if
recombination events were to be
initiated at recombination ‘hot-spots’
such as those known for bacterial
chromosomes [9] the location of these
sites with respect to the
deletion/insertion locus may bias the
recovery of the homologous cross-over
products. It is known, for example,
that such bacterial hot-spots are
orientation-dependent.
In conclusion, we postulate that
the mutant CCR5 ∆32 allele need
not necessarily have achieved 20%
allelic frequency because of selective
pressure from an infectious agent
which utilized the wild-type
receptor, but that it could instead
have arisen by the alternative
mechanisms discussed above.
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Figure 1
Schematic mechanism for the generation of
the CCR5 32 bp deletion. Residues shown
in green constitute repeat regions in the
coding region of the CCR5 gene. Unequal
homologous recombination within these
regions is indicated by the yellow arrow and
leads to the 32 bp deletion observed. The
asterisks indicate nucleotides that differ
between the repeat regions.
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